Inovio Pharmaceuticals Inc (NASDAQ:INO)

4.24
Delayed Data
As of 4:00pm ET
 +0.06 / +1.44%
Today’s Change
3.76
Today|||52-Week Range
9.86
+2.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues13.5M10.5M40.6M35.4M
 
 
 
 
 
Depreciation And Amortization2.1M1.6M1.9M3.1M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses32.9M48.4M73.9M109.5M
 
 
 
 
 
Research And Development21.4M34.1M57.8M88.7M
 
 
 
 
 
Total Operating Expenses35.0M50.0M75.9M112.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.5M-39.5M-35.3M-77.2M
 
 
 
 
 
Extraordinary Credit--3.0M2.8M1.2M
 
 
 
 
Extraordinary Charge-46.7M---274.0K0.00
 
 
 
Other Expenses2.0M331.5K1.6M2.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-66.1M-36.1M-31.2M-73.7M
 
 
 
 
 
Income Taxes0.000.00-2.1M0.00
 
 
Minority Interest-55.1K-18.4K-84.8K0.00
 
 
 
 
Net Income-66.0M-36.1M-29.2M-73.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS46.1M59.1M68.2M73.2M
 
 
 
 
 
Shares To Calculate EPS Diluted46.1M59.4M68.4M73.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.44-$0.64-$0.44-$1.01
 
 
 
 
 
EPS Diluted-$1.44-$0.64-$0.44-$1.01